1. ATP-binding cassette efflux transporters and MDR in cancer
   Manasi S. Pote et al, 2023, Drug Discovery Today CrossRef
2. The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study
   Rishil J. Kathawala et al, 2015, Oncotarget CrossRef
3. ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel
   Rishil J Kathawala et al, 2015, Chinese Journal of Cancer CrossRef
4. Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer
   Pranav Gupta et al, 2016, Expert Opinion on Drug Metabolism & Toxicology CrossRef
5. Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1
   Yi-Jun Wang et al, 2014, Biochemical Pharmacology CrossRef
6. Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance
   Yi-Jun Wang et al, 2014, Cancers CrossRef
7. Mechanistic and Pharmacological Insights into Modulation of ABC Drug Transporters by Tyrosine Kinase Inhibitors
   Suneet Shukla et al, 2016, ABC Transporters - 40 Years on CrossRef
8. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells
   Pranav Gupta et al, 2018, Cellular Physiology and Biochemistry CrossRef
9. Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin
   Zeting Yuan et al, 2017, Oncology Reports CrossRef
10. The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter
    Silpa Narayanan et al, 2021, International Journal of Molecular Sciences CrossRef
11. Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
    Shaocong Wu et al, 2018, Molecular Cancer CrossRef
12. Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
    Maria Krchniakova et al, 2020, International Journal of Molecular Sciences CrossRef
13. Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose‐finding study
    M. A. Pellin et al, 2017, Veterinary and Comparative Oncology CrossRef
14. Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents
    Yun-Kai Zhang et al, 2015, Oncotarget CrossRef
15. A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDRin vitroandin vivo
    Nagaraju Anreddy et al, 2015, Oncotarget CrossRef
16. Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo
    Zhen Chen et al, 2016, Molecular Cancer Therapeutics CrossRef
17. Masitinib analogues with the N-methylpiperazine group replaced – A new hope for the development of anti-COVID-19 drugs
    Arun Bahadur Gurung et al, 2023, Journal of King Saud University - Science CrossRef
18. GSK1904529A, a Potent IGF‐IR Inhibitor, Reverses MRP1‐Mediated Multidrug Resistance
    Pranav Gupta et al, 2017, Journal of Cellular Biochemistry CrossRef
19. Multidrug Efflux Pumps and Their Inhibitors Characterized by Computational Modeling
    Venkata Krishnan Ramaswamy et al, 2016, Efflux-Mediated Antimicrobial Resistance in Bacteria CrossRef
20. Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo
    Ke Yang et al, 2017, Experimental & Molecular Medicine CrossRef
21. Comparison of chemotherapeutic drug resistance in cells transfected with canine ABCG2 or feline ABCG2
    R. S. Lewis et al, 2017, Veterinary and Comparative Oncology CrossRef
22. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo
    Zhiqiang Zhang et al, 2019, Cell Communication and Signaling CrossRef
23. The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
    Rishil J. Kathawala et al, 2015, Drug Resistance Updates CrossRef
24. Effect of prednisolone pre-treatment on cat lymphoma cell sensitivity towards chemotherapeutic drugs
    Juraj Hlavaty et al, 2021, Research in Veterinary Science CrossRef
25. Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
    Nagaraju Anreddy et al, 2014, Molecules CrossRef